Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Cantor Fitzgerald
Medtronic
Baxter
US Department of Justice

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 10,221,244

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,221,244
Title:Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
Abstract: Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
Inventor(s): Wong; Brian (Los Altos, CA), Hambleton; Julie (San Francisco, CA), Sikorski; Robert (Woodside, CA), Masteller; Emma (Redwood City, CA), Hestir; Kevin (Kensington, CA), Bellovin; David (San Jose, CA), Lewis; Katherine E. (Lake Forest Park, WA)
Assignee: Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:15/680,664
Patent Claims:see list of patent claims

Details for Patent 10,221,244

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04   Try a Free Trial Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04   Try a Free Trial Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23   Try a Free Trial Five Prime Therapeutics, Inc. (South San Francisco, CA) Bristol-Myers Squibb Company (Princeton, NJ) 2034-10-29 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Boehringer Ingelheim
QuintilesIMS
McKinsey
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.